LONDON: MGC Pharmaceuticals Ltd (ASX: MXC) announced the successful submission of a patent application for CimetrA to the Slovenian Intellectual Property Office (SIPO), assigned to MGC Pharma. MGC Pharma submitted its patent application which was accepted by SIPO on 5 May 2021 which is the priority date for the patent, giving the Company priority to…
LONDON: MGC Pharmaceuticals Ltd announced the acquisition of 100% of the issued share capital of MediCaNL Inc. MediCaNL Inc is the holding company of MediCaNL Israel 2019 Ltd, an Israeli company operating in and providing specialist services to the pharmaceutical sector for development of new medicines. MediCaNL offers clinical and preclinical trial services, as well…
PERTH: MGC Pharmaceuticals Ltd, a European based bio-pharma company has signed a binding term sheet with Cannvalate Pty Ltd (CVL) to acquire 100% of the operating clinic based assets, data and intellectual property of its wholly owned subsidiary Medicinal Cannabis Clinic Pty Ltd, a news release said. Consideration due for the acquisition upon completion of…